Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 277 No 7408 p38
8 July 2006

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Flu vaccine delay expected, so prioritise patients

Initial deliveries of influenza vaccine for the 2006–07 season could be insufficient to meet demand, with subsequent supplies delayed, a UK Vaccine Industry Group (UVIG) statement has warned. The announcement has prompted advice on who should be prioritised for vaccination, in letters from the Department of Health (PDF, 85K)and the Scottish Executive Health Department to GPs and primary care organisations.

UVIG says that the delay will affect all manufacturers of the vaccine because of the low manufacturing yield of a particular H3N2 strain recommended this year by the World Health Organization. The Government is urging primary care organisations to have local strategies in place to respond to procurement and distribution difficulties. Priority should be given to all persons aged 65 years or over and all those over six months of age with the following risk factors (as recommended by the Joint Committee on Vaccination and Immunisation):

·  Chronic respiratory disease and asthma that requires continuous or repeated use of inhaled or systemic steroids or with previous exacerbations requiring hospital admission

·  Chronic heart disease

·  Chronic renal disease

·  Chronic liver disease

·  Diabetes requiring insulin or oral hypoglycaemic drugs

·  Immunosuppressed patients

Community pharmacists in Scotland are responsible for procuring influenza vaccines on behalf of GPs. Alex MacKinnon, head of professional services development communication and external relations at the Scottish Pharmaceutical General Council, said that the council has encouraged contractors to place vaccine orders with their regular suppliers.“ The SPGC will continue to monitor the situation at this stage.We continue to work closely with the SEHD to minimise any risks,” he said. “The biggest worry is GPs booking a vaccination clinic but the stock not being available when it is needed,” he added.

Further details about any possible delays are expected from manufacturers in late July and throughout August.

Back to Top


©The Pharmaceutical Journal